Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 21, 2026; 32(43): 121829
Published online Nov 21, 2026. doi: 10.3748/wjg.121829
Published online Nov 21, 2026. doi: 10.3748/wjg.121829
Figure 3 Eukaryotic translation initiation factor 5B drove colonic adenocarcinoma cell migratory and invasive phenotypes.
A and B: Transwell migration and invasion assays of eukaryotic translation initiation factor 5B (EIF5B)-overexpressing colonic adenocarcinoma (COAD) cells; C and D: Transwell migration and invasion assays of EIF5B-knockdown COAD cells. All photomicrographs were captured at 200 × magnification. n = 3 independent experiments, with values expressed as the mean ± SD. Independent-samples t-test and non-parametric tests were used for two-group comparisons. aP < 0.01. bP < 0.001. LV-EIF5B: Lentivirus expressing EIF5B; LV-NC: Lentivirus negative control; NC: Negative control; sh-EIF5B: Short hairpin RNA targeting EIF5B; sh-NC: Short hairpin RNA negative control.
- Citation: Li WX, Shi QZ, Mu YH, Li CL, Khan S, Zhao WC, Han N. EIF5B/mitogen-activated protein kinase 1 axis drives tumor progression and confers dual resistance to chemotherapy and immunotherapy in colonic adenocarcinoma. World J Gastroenterol 2026; 32(43): 121829
- URL: https://www.wjgnet.com/1007-9327/full/v32/i43/121829.htm
- DOI: https://dx.doi.org/10.3748/wjg.121829